Translational Development Acquisition Corp. SEC filings TDACW

Translational Development Acquisition Corp. has 80 filings in SEC EDGAR's recent list, going back to Jun 13, 2022. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jul 27, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.

Translational Development Acquisition Corp. SEC filings
Form Description Filed Period
8-K Current report
Material agreement, Unregistered share sale
Jul 27, 2026 Jul 27, 2026
8-K Current report
Other events
Jul 8, 2026 Jul 6, 2026
8-K Current report
Other events
Jun 23, 2026 Jun 22, 2026
8-K Current report
Material agreement, Bylaw or fiscal year change, Shareholder vote results
Jun 18, 2026 Jun 17, 2026
8-K Current report
Unregistered share sale
Jun 12, 2026 Jun 12, 2026
8-K Current report
Material agreement, Regulation FD disclosure
May 27, 2026 May 27, 2026
8-K Current report
New debt, Other events
Aug 14, 2025 Aug 8, 2025
8-K Current report
Other events
Feb 14, 2025 Feb 14, 2025
8-K Current report
Other events
Dec 31, 2024 Dec 24, 2024
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Other events
Dec 27, 2024 Dec 20, 2024

Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Blank Checks (SIC 6770)
Listed as
TDAC (Nasdaq), TDACU (Nasdaq), TDACW (Nasdaq)
Fiscal year ends
December 31
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1926599

Other Blank Checks companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.